多天线糖链对运铁蛋白与受体结合及内吞的研究

应用系列凝集素柱层析法（伴刀豆球蛋白,小扁豆凝集素,欧曼陀罗凝集素）分别从正常人血清及孕妇血清中提纯含有二天线无核心岩藻糖复杂型糖链的运铁蛋白及含有多天线无核心岩藻糖复杂型糖链的运铁蛋白,与正常的含有二天线糖链的运铁蛋白相比,含有多天线糖链的运铁蛋白,与正常的含有二天线糖链的运铁蛋白相比,含有多天线糖链的运铁蛋白与ＳＭＭＣ－７７２１细胞膜表面的运铁蛋白受体的亲和力下降,但最大结合量不变,此外,其在     

地衣霉素对细胞膜表面运铁蛋白受体功能的影响

应用抑制糖蛋白Ｎ－糖链合成的地衣霉素处理ＳＭＭＣ－７７２１人肝癌细胞,３Ｈ甘露糖掺入实验显示细胞表面糖蛋白Ｎ－糖链的合成受到显著抑制,但细胞膜表面运铁蛋白受体内吞再循环的过程无显明变化,进一步的研究表明受体与运铁蛋白的亲和力亦无改变,但细胞膜表面运铁蛋白受体数减少。结果提示用地衣霉素处理细胞后,在内质网合成的无Ｎ－糖链的运铁蛋白受体影响其运输到细胞膜表面表达。     

衣霉素对胰岛素受体结合胰岛素及内吞作用的影响

本文研究了人肝癌细胞ＳＭＭＣ－７７２１的胰岛素受体与＾１２５Ｉ－胰岛素结合的条件,并比较了衣霉素处理和对照细胞的结合动力学和内吞作用。结果表明：４℃和ＰＨ８是研究胰岛素受体与配体结合的较佳条件,当０．１ｕｇ／ｍｌ衣霉素处理１８小时,Ｓｃａｔｓｈａｒｄ作图分析指出,胰岛素受体的结合容量降低,每个细胞上的受体位点数减少。Ｈｉｌｌ作图分析说明,胰岛素和受体的亲和力（胰岛素半饱和浓度和表观解离常数）及结合     

地衣霉素对细胞膜表面运铁蛋白受体功能的影响

应用抑制糖蛋白Ｎ－糖链合成的地衣霉素处理ＳＭＭＣ－７７２１人肝癌细胞,３Ｈ甘露糖掺入实验显示细胞膜表面糖蛋白Ｎ－糖链的合成受到显著抑制,但细胞膜表面运铁蛋白受体内吞再循环的过程无显明变化,进一步的研究表明受体与运铁蛋白的亲和力亦无改变,但细胞膜表面运铁蛋白受体数减少。结果提示用地衣霉素处理细胞后,在内质网合成的无Ｎ－糖链的运铁蛋白受体影响其运输到细胞膜表面表达。     

转铁蛋白糖链结构对其受体亲和性的影响

用伴刀豆凝集素,小扁豆凝集素和欧曼陀罗凝集素亲和层析法,分别从正常人血清转铁蛋白和孕妇血清Ｔｆ中获得二天线糖链Ｔｆ和多天线糖链的Ｔｆ,用于研究其对胎盘中纯化得到的转铁蛋白受体和亲和性。经Ｓｃａｔｃｈａｒｄ作图结果发现,表明含多天线糖链的Ｔｆ对受体的亲和性比二天线糖链的Ｔｆ降低１倍,而ＴｆＲ的结合位点数不变。     

转铁蛋白糖链结构对受体亲和性的影响

用伴刀豆凝集素（ＣｏｎＡ）,小扁豆凝集素（ＬＣＡ）,和欧曼陀罗凝集素（ＤＳＡ）亲和层析法,分别从正常人血清转铁蛋白（Ｔｆ）和孕妇血清Ｔｆ中获得二天线糖链的Ｔｆ和多天线糖链的Ｔｆ．用于研究其对从胎盘中纯化得到的转铁蛋白受体（ＴｆＲ）的亲和性。经Ｓｃａｔｃｈａｒｄ作图结果发现,解离常数分别为：４．９７×１０－８ｍｏｌ／Ｌ和９．８０×１０－８ｍｏｌ／Ｌ．最大结合分别是１８０ｆｍｏｌ／Ｌ和１８２ｆｍｏｌ／Ｌ,表明含多天线糖链的Ｔｆ对受体的亲和性比二天线糖链的Ｔｆ降低１倍,而ＴｆＲ的结合位点数不变。     

糖链的生物质谱分析

糖链是重要的生物信息分子,在许多生理和病理过程中都发挥着独特作用。糖链结构非常复杂,具有微观不均一性,其分析和结构解析一直是糖生物学研究的瓶颈。质谱具有灵敏度高、可获得多种结构信息和适于分析混合物等优点,是糖链定性定量分析的一种理想手段。电喷雾电离质谱和基质辅助激光解析电离质谱两大生物质谱技术已被广泛应用于糖链的相对分子质量指纹谱分析、序列和连接方式测定及相对定量分析。对近年来以质谱为主要分析手段的糖链分析方法研究进展做一综述。     

流感病毒识别糖链受体分子机制的研究进展

近年来,由于流感病毒(influenza virus)不可预测的局部流行和有可能引发全球大流行,其一直是研究的热点课题之一．流感病毒表面糖蛋白血凝素(hemagglutinin,HA)特异识别宿主细胞表面的糖链受体是流感病毒感染宿主、进而复制并继续传播的生物学基础．影响流感病毒宿主特异性的两个主要因素是HA自身的变化(包括基因突变、重组、糖基化位点数量和糖基化位置的变化)和宿主细胞表面糖链受体的变化(包括糖链受体的类型、分布和分子构象的改变)等．因此准确掌握这些信息有助于人们进一步加强对流感病毒的防控．本文主要从糖组学角度概述了流感病毒识别糖链受体的分子机制,重点介绍流感病毒宿主细胞表面糖链受体的研究进展．     

视黄酸对人肝癌细胞表面N糖链类型及天线数的影响

本文采用系列凝集素柱层析法,并配合外切糖苷酶处理研究了在视黄酸作用１－５天过程中人肝癌细胞株ＳＭＭＣ－７７２１细胞表面Ｎ糖结构的变化。结果表明,ＲＡ促进＾３Ｈ－甘露糖参入细胞表面Ｎ糖链,使高甘露糖型Ｎ糖的百分比下降,复杂型百分比长升,并促进二天线Ｎ糖链的生物合成,使多天线特别是四天线和Ｃ２,Ｃ２１ｂ三天线Ｎ糖链的合成减少。结果提示,Ｎ糖链结构的这些变化可能是ＲＡ诱导ＳＭＭＣ－７７２１细胞向正常方向     

N－糖链在纤连蛋白分泌及纤连蛋白受体与配体结合中的作用

应用能阻断糖蛋白Ｎ－糖链合成的衣霉素（ＴＭ）,研究了Ｎ－糖链缺失对ＨＴ１０８０细胞分泌纤连蛋白（Ｆｎ）以及纤连蛋白受体（ＦｎＲ）与配体结合的影响。结果发现,１μｇ／ｍｌ的ＴＭ可抑制Ｎ－糖链的合成（此时,３Ｈ－甘露糖掺入下降６３％）,但细胞分泌Ｆｎ的量仅下降３３％,这主要是由于蛋白合成受ＴＭ抑制（２５％）而引起,因而,Ｎ－糖链缺失可能并不影响Ｆｎ的分泌。而在同样条件下,单个细胞结合１２５Ｉ－Ｆｎ的量显著下降,显示Ｎ－糖链的缺失可能导致了膜上ＦｎＲ总量或其与配体结合的亲和力的改变。ＴＭ处理组的ＦｎＲ的内吞率与对照组相比较无明显差异,提示受体分子中的Ｎ－糖链缺失不影响其内吞过程．     

人胚肺成纤维细胞株纤连蛋白结构域N─糖链结构研究

本文应用明胶、肝素亲和层析二步法首先纯化了人胚肺成纤维细胞培养液的纤连蛋白（Ｆｉｂｒｏｎｅｏｔｈｅ,Ｆｎ）,经ＳＤＳ－ＰＡＧＥ鉴定为一条带,然后用胰糜蛋白酶消化纯化的Ｆｎ所获得的酶解波,经分离分别得到明胶结合片段和肝素结合片段,再应用凝集素－ＨＲＰ染色的Ｗｅｓｔｅｎ转移电泳法研究糖链结构,结果证实：１．Ｆｎ中明胶结合片段（４４ｋｄ）中含有二天线和多天线复杂型糖链,并接有平分型ｇｌｃＮＡｃ糖基、核心力Ｆｕｃ。２肝素结合片段（３０ｋｄ）只含有二天线复杂型糖链,不含平分型ＧｌｃＮＡｃ糖基及核心Ｆｕｃ．     

人胎盘纤连蛋白N糖链结构研究

分离纯化了人胎盘纤连蛋白（Ｆｎ）,经ＳＤＳ－ＰＡＧＥ鉴定为一条带,纯化Ｆｎ仍保持其搞原性,得率为３８．７％。根据植物凝集素识别专一糖链结构的原理,应用斑点印迹法,亲和层析法和Ｗｅｓｔｅｒｎ转移电泳研究糖链结构,结果证实：１．人胎盘Ｆｎ分子中含有复杂型Ｎ糖链（包括二天线和大于二天线的结构）以及高甘露糖型和／或杂合型Ｎ糖链;复杂型Ｎ糖链中含有平分型ＧｌｃＮＡｃ,糖链末端也可连有唾液酸;２．胰糜蛋白酶水解而获得的明胶结合片段（４４ｋＤ）含有二天线和多天线复杂型糖链,也可接有平分型ＧｌｃＮＡｃ;３．肝素结合片段（３０ｋＤ）以及明胶、肝素均不结合的Ｆｎ片段不含有多天线复杂型Ｎ糖链。     

Receptor Binding, Endocytosis, and Mitogenesis of Insulin-Like Growth Factors I and II in Fetal Rat Brain Neurons

Cell surface binding, internalization, and biological effects of insulin-like growth factors (IGFs) I and II have been studied in primary neuronal cultures from developing rat brain (embryonic day 15). Two types of IGF binding sites are present on the cell surface. The IGF-I receptor alpha-subunit (Mr 125,000) binds IGF-I with a KD of 1 nM and IGF-II with 10 times lower affinity. The mannose-6-phosphate (Man-6-P)/IGF-II receptor (Mr 250,000) binds IGF-II with a KD of 0.5 nM and IGF-I with 100 times lower affinity. Surface-bound IGF-I and IGF-II are internalized by their respective receptors binding and internalization of IGF-II but not those of IGF-I. Neuronal synthesis of RNA and DNA is increased twofold by IGF-I with 10 times higher potency than IGF-II. Antibody 3637, which blocks receptor binding of IGF-II, has no effect on the DNA response to IGF-I or IGF-II. Double immunocytochemical staining with antibodies to bromodeoxyuridine and neurofilament shows that greater than 80% of the bromodeoxyuridine-positive cells become neurofilament positive. It is concluded that IGF-I and IGF-II bind to two receptors on the surface of neuronal precursor cells that mediate endocytosis and degradation of IGF-I and IGF-II. Proliferation of neuronal precursor cells is stimulated by IGF-I and IGF-II via activation of the IGF-I receptor.     

青蒿琥酯抑制白血病耐药细胞株K562/ADM转铁蛋白受体表达

目的:观察青蒿琥酯对于白血病多药耐药细胞细胞株K562/ADM转铁蛋白受体表达的影响。方法:将K562/ADM(耐阿霉素)细胞分别经浓度为12.5、25、50μg/m L的青蒿琥酯处理48 h,同时25μg/m L实验组在12 h、24 h、36 h分别收集足量细胞。采用流式细胞术检测青蒿琥酯对细胞转铁蛋白受体(Tf R)密度的调控作用,Western blot检测青蒿琥酯对细胞Tf R蛋白表达的调控作用。CCK-8法分析青蒿琥酯对K562/ADM细胞生长增殖的影响。结果:K562/ADM细胞Tf R密度和Tf R蛋白表达水平分别经12.5、25、50μg/m L青蒿琥酯处理后均下降,呈浓度依赖性。25μg/m L青蒿琥酯处理K562/ADM细胞不同时间段后转铁蛋白受体蛋白表达水平随着Art作用时间延长而逐渐降低,表明呈时间依赖性。K562/ADM细胞经青蒿琥酯处理后其耐药性减弱:与对照组相比,12.5、25、50μg/m L实验组细胞耐药逆转倍数分别为1.38、2.12和2.95倍,从而抑制K562/ADM细胞增殖。IC50值为19.7μmol/L。结论:青蒿琥酯能降低细胞Tf R密度和下调Tf R蛋白的表达,逆转K562/ADM细胞的耐药性,从而起到抗肿瘤作用。     

Interactions of arene-Ru(II)-chloroquine complexes of known antimalarial and antitumor activity with human serum albumin (HSA) and transferrin

The interactions of π-arene-Ru(II)-chloroquine complexes with human serum albumin (HSA), apotransferrin and holotransferrin have been studied by circular dichroism (CD) and UV-Visible spectroscopies, together with isothermal titration calorimetry (ITC). The data for [Ru(η⁶-p-cymene)(CQ)(H₂O)Cl]PF₆ (1), [Ru(η⁶-benzene)(CQ)(H₂O)Cl]PF₆ (2), [Ru(η⁶-p-cymene)(CQ)(H₂O)₂][PF₆]₂ (3), [Ru(η⁶-p-cymene)(CQ)(en)][PF₆]₂ (4), [Ru(η⁶-p-cymene)(η⁶-CQDP)][BF₄]₂ (5) (CQ: chloroquine; DP: diphosphate; en: ethylenediamine), in comparison with CQDP and [Ru(η⁶-p-cymene)(en)Cl][PF₆] (6) as controls demonstrate that 1, 2, 3, and 5, which contain exchangeable ligands, bind to HSA and to apotransferrin in a covalent manner. The interaction did not affect the α-helical content in apotransferrin but resulted in a loss of this type of structure in HSA. The binding was reversed in both cases by a decrease in pH and in the case of the Ru-HSA adducts, also by addition of chelating agents. A weaker interaction between complexes 4 and 6 and HSA was measured by ITC but was not detectable spectroscopically. No interactions were observed for complexes 4 and 6 with apotransferrin or for CQDP with either protein. The combined results suggest that the arene-Ru(II)-chloroquine complexes, known to be active against resistant malaria and several lines of cancer cells, also display a good transport behavior that makes them good candidates for drug development.     

Binding patterns of vanadium ions with different valence states to human serum transferrin studied by HPLC/high-resolution ICP-MS

Vanadium (V) is an essential metal for mammals and has different valence states. In blood, V is bound to serum transferrin (Tf), a glycoprotein which has two metal-binding sites, and carbonate is generally required for the binding. In this study, the binding patterns of V(III), V(IV), and V(V) to human serum Tf (hTf) were analyzed using an HPLC system equipped with an anion-exchange column and directly connected to a high-resolution inductively coupled plasma-mass spectrometer for metal detection (51V). In affinity to hTf, the three ions were ranked V(III)>V(IV)>V(V) in the presence of bicarbonate and V(III) reverse congruent V(IV)>V(V) in the absence. Intermediates in the "open forms" binding to the respective sites were detected at the initial stage. V(IV) and V(V) were bound to the N-lobe site in the "closed form" and "open form," respectively. In the absence of bicarbonate, V ions with respective valence states were bound to hTf in the "open form." In terms of binding to hTf, tri-valent V was most favorable in the presence of bicarbonate.     

Rate of 59Fe Uptake into Brain and Cerebrospinal Fluid and the Influence Thereon of Antibodies Against the Transferrin Receptor

Abstract: Uptake of ⁵⁹Fe from blood into brains of anaesthetized rats and mice has been studied by intravenous infusion of [⁵⁹Fe]ferrous ascorbate or of ⁵⁹Fe-transferrin, the results not being significantly different. Uptakes in the rat were linear with time, but increased at longer times in the mouse. Transfer constants, K _in (in ml/g/h × 10³), for cerebral hemispheres were 5.2 in the adult rat and 5.6 in the mouse. These K _in values corresponded to ⁵⁹Fe influxes of 145 and 322 pmol/g/h, respectively. ⁵⁹Fe uptake into the mouse brain occurred in the following order: cerebellum > brainstem > frontal cerebral cortex > parietal cortex > occipital cortex > hippocampus > caudate nucleus. In genetically hypotransferrinaemic mice, ⁵⁹Fe uptake into brain was 80–95 times greater than in To strain mice. Pretreatment of young rats and mice with monoclonal antibodies to transferrin receptors, i.e., the anti-rat immunoglobulin G OX 26 and the anti-mouse immunoglobulin M RI7 208, inhibited ⁵⁹Fe uptake into spleen by 94% and 98%, respectively, indicating saturation of receptors. The antibodies reduced ⁵⁹Fe uptake into rat brain by 35–60% and that into mouse brain by 65–85%. Although a major portion of iron transport across the blood-brain barrier is normally transferrin-mediated, non-transferrin-bound iron readily crosses it at low serum transferrin levels.